Cigna Group $CI Stake Trimmed by Compass Financial Management LLC

Compass Financial Management LLC reduced its holdings in Cigna Group (NYSE:CI - Free Report) by 95.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 184 shares of the health services provider's stock after selling 4,070 shares during the quarter. Compass Financial Management LLC's holdings in Cigna Group were worth $50,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Rakuten Investment Management Inc. raised its holdings in Cigna Group by 9.8% in the 3rd quarter. Rakuten Investment Management Inc. now owns 47,447 shares of the health services provider's stock worth $13,060,000 after purchasing an additional 4,230 shares in the last quarter. Provenance Wealth Advisors LLC increased its position in shares of Cigna Group by 198.1% during the third quarter. Provenance Wealth Advisors LLC now owns 4,618 shares of the health services provider's stock valued at $1,255,000 after buying an additional 3,069 shares during the period. Lyell Wealth Management LP increased its position in shares of Cigna Group by 4.7% during the third quarter. Lyell Wealth Management LP now owns 915 shares of the health services provider's stock valued at $249,000 after buying an additional 41 shares during the period. Associated Banc Corp purchased a new position in shares of Cigna Group during the third quarter valued at about $16,682,000. Finally, Putney Financial Group LLC bought a new position in Cigna Group in the third quarter worth about $27,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Trading Up 0.0%

Shares of NYSE CI opened at $293.66 on Monday. Cigna Group has a 1 year low of $255.53 and a 1 year high of $318.05. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The firm has a 50-day moving average of $285.81 and a 200 day moving average of $282.17. The stock has a market cap of $77.60 billion, a P/E ratio of 12.96, a price-to-earnings-growth ratio of 1.01 and a beta of 0.25.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, topping analysts' consensus estimates of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The business had revenue of $73.79 billion for the quarter, compared to analysts' expectations of $72.64 billion. During the same quarter in the prior year, the company earned $7.83 earnings per share. The business's revenue was up 5.6% compared to the same quarter last year. As a group, sell-side analysts expect that Cigna Group will post 30.62 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group's payout ratio is currently 27.54%.

Wall Street Analyst Weigh In

Several analysts have commented on CI shares. Raymond James Financial lowered shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and lowered their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Weiss Ratings reissued a "hold (c)" rating on shares of Cigna Group in a research report on Thursday, August 27th. Jefferies Financial Group lowered Cigna Group from a "buy" rating to a "hold" rating and decreased their target price for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Sanford C. Bernstein restated an "outperform" rating on shares of Cigna Group in a research note on Friday, October 2nd. Finally, Barclays lifted their price target on Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $335.70.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.